However, pet owners should not worry as these are not severe side effects for their pets. We advise you to discuss your problems with your veterinarian before giving Bravecto to your dog. Safety was demonstrated in kittens aged 9 – 13 weeks and weighing 0.9 – 1.9 kg treated with overdoses of up to 5 times the maximum recommended dose on three occasions at shorter intervals than recommended (8-week intervals). Mild and transient gastrointestinal effects such as diarrhoea, vomiting, inappetence, and drooling were commonly observed in clinical trials (1.6% of treated dogs). Swimming, shampooing, or bathing shouldn't impact Bravecto's effectiveness. The length of the coat or brushing also has little bearing on how well it functions. A laboratory examined the efficacy of Bravecto chewable tablets and Bravecto. The ideal treatment for dogs with demodectic mange. Based on the percentage of dogs free of live mites at days 56 and 84 after medication, Bravecto chewable pills and Bravecto spot-on treatment were each 95% and 94% helpful. Bravecto

Registered office Walton Manor, Walton, Milton Keynes MK7 7AJ, UK. Registered in England & Wales no. 946942.The product should not be administered at intervals shorter than 8 weeks as the safety for shorter intervals has not been tested. As your dog's health care specialist, your veterinarian is the ideal person to talk to about all of your dog's treatments. Bravecto Authority to prescribe an Authority medicine is granted for specific indications and/or for certain patient circumstances. Authority may be obtained by telephone to Medicare Australia (known as "phone approval") or in writing from an authorised delegate of the Minister for Health. Convulsions have been reported very rarely based on post marketing safety experience (pharmacovigi­lance).

In the absence of available data, the product should not be used on puppies less than 8 weeks old and /or dogs weighing less than 2 kg. No adverse reactions were observed following oral administration to puppies aged 8 – 9 weeks and weighing 2.0 – 3.6 kg treated with overdoses of up to 5 times the maximum recommended dose (56 mg, 168 mg and 280 mg fluralaner/kg body weight) on three occasions at shorter intervals than recommended (8-week intervals).

Prescription is less likely to be forgotten because it requires up to two-thirds less dosage than monthly therapy. Bravecto is a chewable tablet and is well accepted by most dogs. If the tablet is not taken up voluntarily by the dog it can also be given with food or directly into the mouth. The dog should be observed during administration to confirm that the tablet is swallowed.

The veterinary medicinal product was well tolerated in Collies with a deficient multidrug-resistance-protein 1 (MDR1 -/-) following single oral administration at 3 times the recommended dose (168 mg/kg body weight). No treatment-related clinical signs were observed. Extra-large breed dogs ranging 88-123 lbs must have one 1400mg dose every three months, whereas big breed dogs between 44-88 lbs must take one 1000mg chew or pipette. You must provide a mixture of chews and pipettes to dogs weighing more than 123 pounds. Oral uptake of the product at the maximum recommended dose was well tolerated in cats, apart from some self-limiting salivation and coughing or vomiting immediately after administration. Fluralaner is highly bound to plasma proteins and might compete with other highly bound active substances such as non-steroidal anti-inflammatory drugs (NSAIDs) and the coumarin derivative warfarin. Incubation of fluralaner in the presence of carprofen or warfarin in dog plasma at maximum expected plasma concentrations did not reduce the protein binding of fluralaner, carprofen or warfarin. During laboratory and clinical field testing, no interactions between Bravecto spot-on solution for dogs and routinely used veterinary medicinal products were observed.In Europe, two field studies and one laboratory trial demonstrated the efficacy of chewable Bravecto pills in stopping the spread of B. D.'s "canis canis" reticulatus in dogs for up to 12 weeks. Depending on the existence of live ear mites at day 28 after treatment, Bravecto's efficacy in research with cats that had ear mites in the EU was greater than 90%. Types of Bravecto The product can be used as part of a treatment strategy for the control of flea allergy dermatitis (FAD).

Safety was demonstrated in breeding, pregnant and lactating animals treated with overdoses of up to 3 times the maximum recommended dose. Squeeze the pipette gently and apply the entire contents directly to the dog’s skin in one or several spots. The product is highly flammable. Keep away from heat, sparks, open flame or other sources of ignition. In case of spillage onto, for example table or floor surfaces, remove excess product using paper tissue and clean the area with detergent. A few dogs who consume a chew may briefly appear too thirsty afterward; unless this behavior develops, it is nothing to worry about. Lethargy, muscle tremor, ataxia and convulsions have been reported very rarely in spontaneous reports.

How Can You Use Bravecto? 

For the treatment of Demodex canis mite infestations, a single dose of the product should be administered. As demodicosis is a multi-factorial disease, it is advisable to also treat any underlying disease appropriately. This veterinary medicinal product was well tolerated in collies with a deficient multidrug-resistance-protein 1 (MDR1 -/-) following single oral administration at 3 times the maximum recommended dose. For the treatment of sarcoptic mange infestations (Sarcoptes scabiei var. canis), a single dose of the product should be administered. The need for and frequency of re-treatment should be in accordance with the advice of the prescribing veterinarian. Bravecto ® Spot-on for Cats and Bravecto ® Chewable Tablets and Spot-on for Dogs contain fluralaner. POM-V. To prevent kids from getting to the medication directly, you must store it in sealed containers until usage. Individuals had experienced hypersensitivity ('allergic') effects to the medication. When administering the drug, users must refrain from eating, drinking, or smoking and promptly wash their hands with soap and water.